1
|
Karges J, Jakubaszek M, Mari C, Zarschler K, Goud B, Stephan H, Gasser G. Synthesis and Characterization of an Epidermal Growth Factor Receptor-Selective Ru II Polypyridyl-Nanobody Conjugate as a Photosensitizer for Photodynamic Therapy. Chembiochem 2020; 21:531-542. [PMID: 31339225 PMCID: PMC7065149 DOI: 10.1002/cbic.201900419] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2019] [Indexed: 02/06/2023]
Abstract
There is a current surge of interest in the development of novel photosensitizers (PSs) for photodynamic therapy (PDT), as those currently approved are not completely ideal. Among the tested compounds, we have previously investigated the use of RuII polypyridyl complexes with a [Ru(bipy)2 (dppz)]2+ and [Ru(phen)2 (dppz)]2+ scaffold (bipy=2,2'-bipyridine; dppz=dipyrido[3,2-a:2',3'-c]phenazine; phen=1,10-phenanthroline). These complexes selectively target DNA. However, because DNA is ubiquitous, it would be of great interest to increase the selectivity of our PDT PSs by linking them to a targeting vector in view of targeted PDT. Herein, we present the synthesis, characterization, and in-depth photophysical evaluation of a nanobody-containing RuII polypyridyl conjugate selective for the epidermal growth factor receptor (EGFR) in view of targeted PDT. Using ICP-MS and confocal microscopy, we could demonstrate that our conjugate has high selectivity for the EGFR receptor, which is a crucial oncological target because it is overexpressed and/or deregulated in a variety of solid tumors. However, in contrast to expectations, this conjugate was found to not produce reactive oxygen species (ROS) in cancer cells and is therefore not phototoxic.
Collapse
Affiliation(s)
- Johannes Karges
- Chimie ParisTechPSL UniversityCNRSInstitute of Chemistry for Life and Health SciencesLaboratory for Inorganic Chemical Biology75005ParisFrance
| | - Marta Jakubaszek
- Chimie ParisTechPSL UniversityCNRSInstitute of Chemistry for Life and Health SciencesLaboratory for Inorganic Chemical Biology75005ParisFrance
- Institut CuriePSL UniversityCNRS UMR 14426 rue d'Ulm75005ParisFrance
| | - Cristina Mari
- Department of ChemistryUniversity of ZürichWinterthurerstrasse 1908057ZürichSwitzerland
| | - Kristof Zarschler
- Helmholtz-Zentrum Dresden–RossendorfInstitute of Radiopharmaceutical Cancer ResearchBautzner Landstrasse 40001328DresdenGermany
| | - Bruno Goud
- Institut CuriePSL UniversityCNRS UMR 14426 rue d'Ulm75005ParisFrance
| | - Holger Stephan
- Helmholtz-Zentrum Dresden–RossendorfInstitute of Radiopharmaceutical Cancer ResearchBautzner Landstrasse 40001328DresdenGermany
| | - Gilles Gasser
- Chimie ParisTechPSL UniversityCNRSInstitute of Chemistry for Life and Health SciencesLaboratory for Inorganic Chemical Biology75005ParisFrance
| |
Collapse
|
2
|
Zia NA, Cullinane C, Van Zuylekom JK, Waldeck K, McInnes LE, Buncic G, Haskali MB, Roselt PD, Hicks RJ, Donnelly PS. A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention. Angew Chem Int Ed Engl 2019. [DOI: 10.1002/ange.201908964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Nicholas A. Zia
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute University of Melbourne Melbourne 3010 Vic. Australia
| | - Carleen Cullinane
- Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne 3010 Vic. Australia
- Research Division Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
| | | | - Kelly Waldeck
- Research Division Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
| | - Lachlan E. McInnes
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute University of Melbourne Melbourne 3010 Vic. Australia
| | - Gojko Buncic
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute University of Melbourne Melbourne 3010 Vic. Australia
| | - Mohammad B. Haskali
- Centre for Cancer Imaging Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
| | - Peter D. Roselt
- Centre for Cancer Imaging Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
| | - Rodney J. Hicks
- Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne 3010 Vic. Australia
- Research Division Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
- Centre for Cancer Imaging Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
| | - Paul S. Donnelly
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute University of Melbourne Melbourne 3010 Vic. Australia
| |
Collapse
|
3
|
Zia NA, Cullinane C, Van Zuylekom JK, Waldeck K, McInnes LE, Buncic G, Haskali MB, Roselt PD, Hicks RJ, Donnelly PS. A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention. Angew Chem Int Ed Engl 2019; 58:14991-14994. [DOI: 10.1002/anie.201908964] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Indexed: 11/08/2022]
Affiliation(s)
- Nicholas A. Zia
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute University of Melbourne Melbourne 3010 Vic. Australia
| | - Carleen Cullinane
- Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne 3010 Vic. Australia
- Research Division Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
| | | | - Kelly Waldeck
- Research Division Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
| | - Lachlan E. McInnes
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute University of Melbourne Melbourne 3010 Vic. Australia
| | - Gojko Buncic
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute University of Melbourne Melbourne 3010 Vic. Australia
| | - Mohammad B. Haskali
- Centre for Cancer Imaging Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
| | - Peter D. Roselt
- Centre for Cancer Imaging Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
| | - Rodney J. Hicks
- Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne 3010 Vic. Australia
- Research Division Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
- Centre for Cancer Imaging Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia
| | - Paul S. Donnelly
- School of Chemistry and Bio21 Molecular Science and Biotechnology Institute University of Melbourne Melbourne 3010 Vic. Australia
| |
Collapse
|
4
|
Siegmund V, Schmelz S, Dickgiesser S, Beck J, Ebenig A, Fittler H, Frauendorf H, Piater B, Betz UAK, Avrutina O, Scrima A, Fuchsbauer H, Kolmar H. Locked by Design: A Conformationally Constrained Transglutaminase Tag Enables Efficient Site‐Specific Conjugation. Angew Chem Int Ed Engl 2015; 54:13420-4. [DOI: 10.1002/anie.201504851] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2015] [Indexed: 11/08/2022]
Affiliation(s)
- Vanessa Siegmund
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Germany)
| | - Stefan Schmelz
- Arbeitsgruppe Strukturbiologie der Autophagie, Abteilung Struktur und Funktion der Proteine, Helmholtz‐Zentrum für Infektionsforschung, Inhoffenstr. 7, 38124 Braunschweig (Germany)
| | - Stephan Dickgiesser
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Germany)
| | - Jan Beck
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Germany)
| | - Aileen Ebenig
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Germany)
| | - Heiko Fittler
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Germany)
| | - Holm Frauendorf
- Institut für Organische und Biomolekulare Chemie, Zentrale Analytik/Massenspektrometrie, Georg‐August‐Universität Göttingen, Tammannstr. 2, 37077 Göttingen (Germany)
| | - Birgit Piater
- Merck KGaA, Frankfurterstr. 250, 64293 Darmstadt (Germany)
| | | | - Olga Avrutina
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Germany)
| | - Andrea Scrima
- Arbeitsgruppe Strukturbiologie der Autophagie, Abteilung Struktur und Funktion der Proteine, Helmholtz‐Zentrum für Infektionsforschung, Inhoffenstr. 7, 38124 Braunschweig (Germany)
| | - Hans‐Lothar Fuchsbauer
- Fachbereich Chemie‐ und Biotechnologie, Hochschule Darmstadt, Schnittspahnstraße 12, 64287 Darmstadt (Germany)
| | - Harald Kolmar
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Germany)
| |
Collapse
|
5
|
Siegmund V, Schmelz S, Dickgiesser S, Beck J, Ebenig A, Fittler H, Frauendorf H, Piater B, Betz UAK, Avrutina O, Scrima A, Fuchsbauer H, Kolmar H. Durch Design verbrückt: ein konformativ eingeschränkter Transglutaminase‐Marker ermöglicht effiziente ortsspezifische Konjugation. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201504851] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Vanessa Siegmund
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Deutschland)
| | - Stefan Schmelz
- Arbeitsgruppe Strukturbiologie der Autophagie, Abteilung Struktur und Funktion der Proteine, Helmholtz‐Zentrum für Infektionsforschung, Braunschweig (Deutschland)
| | - Stephan Dickgiesser
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Deutschland)
| | - Jan Beck
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Deutschland)
| | - Aileen Ebenig
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Deutschland)
| | - Heiko Fittler
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Deutschland)
| | - Holm Frauendorf
- Institut für Organische und Biomolekulare Chemie, Zentrale Analytik/Massenspektrometrie, Universität Göttingen (Deutschland)
| | | | | | - Olga Avrutina
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Deutschland)
| | - Andrea Scrima
- Arbeitsgruppe Strukturbiologie der Autophagie, Abteilung Struktur und Funktion der Proteine, Helmholtz‐Zentrum für Infektionsforschung, Braunschweig (Deutschland)
| | | | - Harald Kolmar
- Clemens‐Schöpf‐Institut für Organische Chemie und Biochemie, Technische Universität Darmstadt, Alarich‐Weiss‐Straße 4, 64287 Darmstadt (Deutschland)
| |
Collapse
|
6
|
Lee JJ, Choi HJ, Yun M, Kang Y, Jung JE, Ryu Y, Kim TY, Cha YJ, Cho HS, Min JJ, Chung CW, Kim HS. Enzymatic Prenylation and Oxime Ligation for the Synthesis of Stable and Homogeneous Protein-Drug Conjugates for Targeted Therapy. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201505964] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
7
|
Lee JJ, Choi HJ, Yun M, Kang Y, Jung JE, Ryu Y, Kim TY, Cha YJ, Cho HS, Min JJ, Chung CW, Kim HS. Enzymatic prenylation and oxime ligation for the synthesis of stable and homogeneous protein-drug conjugates for targeted therapy. Angew Chem Int Ed Engl 2015; 54:12020-4. [PMID: 26315561 DOI: 10.1002/anie.201505964] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2015] [Indexed: 12/30/2022]
Abstract
Targeted therapy based on protein-drug conjugates has attracted significant attention owing to its high efficacy and low side effects. However, efficient and stable drug conjugation to a protein binder remains a challenge. Herein, a chemoenzymatic method to generate highly stable and homogenous drug conjugates with high efficiency is presented. The approach comprises the insertion of the CaaX sequence at the C-terminal end of the protein binder, prenylation using farnesyltransferase, and drug conjugation through an oxime ligation reaction. MMAF and an EGFR-specific repebody are used as the antitumor agent and protein binder, respectively. The method enables the precisely controlled synthesis of repebody-drug conjugates with high yield and homogeneity. The utility of this approach is illustrated by the notable stability of the repebody-drug conjugates in human plasma, negligible off-target effects, and a remarkable antitumor activity in vivo. The present method can be widely used for generating highly homogeneous and stable PDCs for targeted therapy.
Collapse
Affiliation(s)
- Joong-Jae Lee
- Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon (Korea)
| | - Hyo-Jung Choi
- New Drug Research Center, LegoChem Biosciences, Inc., Daejeon (Korea)
| | - Misun Yun
- Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju (Korea)
| | - YingJin Kang
- Department of Systems Biology, Yonsei University, Seoul (Korea)
| | - Ji-Eun Jung
- New Drug Research Center, LegoChem Biosciences, Inc., Daejeon (Korea)
| | - Yiseul Ryu
- Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon (Korea)
| | - Tae Yoon Kim
- Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon (Korea)
| | - Young-Je Cha
- Department of Systems Biology, Yonsei University, Seoul (Korea)
| | - Hyun-Soo Cho
- Department of Systems Biology, Yonsei University, Seoul (Korea).
| | - Jung-Joon Min
- Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju (Korea).
| | - Chul-Woong Chung
- New Drug Research Center, LegoChem Biosciences, Inc., Daejeon (Korea).
| | - Hak-Sung Kim
- Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon (Korea).
| |
Collapse
|
8
|
Alt K, Paterson BM, Westein E, Rudd SE, Poniger SS, Jagdale S, Ardipradja K, Connell TU, Krippner GY, Nair AKN, Wang X, Tochon-Danguy HJ, Donnelly PS, Peter K, Hagemeyer CE. A versatile approach for the site-specific modification of recombinant antibodies using a combination of enzyme-mediated bioconjugation and click chemistry. Angew Chem Int Ed Engl 2015; 54:7515-9. [PMID: 25962581 DOI: 10.1002/anie.201411507] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2014] [Revised: 02/24/2015] [Indexed: 12/16/2022]
Abstract
A unique two-step modular system for site-specific antibody modification and conjugation is reported. The first step of this approach uses enzymatic bioconjugation with the transpeptidase Sortase A for incorporation of strained cyclooctyne functional groups. The second step of this modular approach involves the azide-alkyne cycloaddition click reaction. The versatility of the two-step approach has been exemplified by the selective incorporation of fluorescent dyes and a positron-emitting copper-64 radiotracer for fluorescence and positron-emission tomography imaging of activated platelets, platelet aggregates, and thrombi, respectively. This flexible and versatile approach could be readily adapted to incorporate a large array of tailor-made functional groups using reliable click chemistry whilst preserving the activity of the antibody or other sensitive biological macromolecules.
Collapse
Affiliation(s)
- Karen Alt
- Vascular Biotechnology, Baker IDI, Melbourne (Australia).
| | - Brett M Paterson
- School of Chemistry/Bio21 Institute, University of Melbourne (Australia)
| | - Erik Westein
- Atherothrombosis and Vascular Biology, Baker IDI, Melbourne (Australia)
| | - Stacey E Rudd
- School of Chemistry/Bio21 Institute, University of Melbourne (Australia)
| | - Stan S Poniger
- Department of Molecular Imaging and Therapy, Austin Health, Melbourne (Australia)
| | - Shweta Jagdale
- Vascular Biotechnology, Baker IDI, Melbourne (Australia)
| | | | - Timothy U Connell
- School of Chemistry/Bio21 Institute, University of Melbourne (Australia)
| | - Guy Y Krippner
- Vascular Biotechnology, Baker IDI, Melbourne (Australia)
| | - Ashish K N Nair
- Atherothrombosis and Vascular Biology, Baker IDI, Melbourne (Australia)
| | - Xiaowei Wang
- Atherothrombosis and Vascular Biology, Baker IDI, Melbourne (Australia)
| | | | - Paul S Donnelly
- School of Chemistry/Bio21 Institute, University of Melbourne (Australia).
| | - Karlheinz Peter
- Atherothrombosis and Vascular Biology, Baker IDI, Melbourne (Australia)
| | | |
Collapse
|
9
|
Alt K, Paterson BM, Westein E, Rudd SE, Poniger SS, Jagdale S, Ardipradja K, Connell TU, Krippner GY, Nair AKN, Wang X, Tochon-Danguy HJ, Donnelly PS, Peter K, Hagemeyer CE. A Versatile Approach for the Site-Specific Modification of Recombinant Antibodies Using a Combination of Enzyme-Mediated Bioconjugation and Click Chemistry. Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201411507] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
10
|
Policarpo RL, Kang H, Liao X, Rabideau AE, Simon MD, Pentelute BL. Flow-based enzymatic ligation by sortase A. Angew Chem Int Ed Engl 2014; 53:9203-8. [PMID: 24989829 DOI: 10.1002/anie.201403582] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2014] [Indexed: 02/03/2023]
Abstract
Sortase-mediated ligation (sortagging) is a versatile, powerful strategy for protein modification. Because the sortase reaction reaches equilibrium, a large excess of polyglycine nucleophile is often employed to drive the reaction forward and suppress sortase-mediated side reactions. A flow-based sortagging platform employing immobilized sortase A within a microreactor was developed that permits efficient sortagging at low nucleophile concentrations. The platform was tested with several reaction partners and used to generate a protein bioconjugate inaccessible by solution-phase batch sortagging.
Collapse
Affiliation(s)
- Rocco L Policarpo
- Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139 (USA)
| | | | | | | | | | | |
Collapse
|
11
|
Policarpo RL, Kang H, Liao X, Rabideau AE, Simon MD, Pentelute BL. Flow-Based Enzymatic Ligation by Sortase A. Angew Chem Int Ed Engl 2014. [DOI: 10.1002/ange.201403582] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
12
|
Abstract
Bioorthogonal, chemoselective ligation methods are an essential part of the tools utilized to investigate biochemical pathways. Specifically enzymatic approaches are valuable methods in this context due to the inherent specificity of the deployed enzymes and the mild conditions of the modification reactions. One of the most common strategies is based on the transpeptidation catalyzed by sortase A derived from Staphylococcus aureus. The procedure is well established and a wide variety of applications have been published to date. Here, implementations of sortase A, which range from protein labeling using fluorescence dyes and the preparation of cyclic proteins to the modification of entire cells, are summarized. Furthermore, there is a focus on the optimization approaches established to solve the drawbacks of sortase-mediated transpeptidation.
Collapse
Affiliation(s)
- Markus Ritzefeld
- Bielefeld University, Department of Chemistry, Organic and Bioorganic Chemistry (OCIII), Universitätsstrasse 25, 33615 Bielefeld (Germany).
| |
Collapse
|